Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

novartissunlight_copy

Novartis misses Q3 forecast with $390m settlement payment, strong dollar

October 27, 2015 Manufacturing and Production, Sales and Marketing Alcon, Novartis, Sandoz

Novartis reported lower-than anticipated third quarter earnings on Tuesday, hit by the $390 million settlement it has agreed to pay …
News
j

Valeant CEO rejects fraud accusations in conference call

October 27, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing

Valeant says it will establish a committee to review allegations about the company’s relationship with specialist pharmacy Philidor, following what …
News
gsk_hq

GSK’s Volibris gets pulmonary arterial hypertension approval in Europe

October 26, 2015 Research and Development, Sales and Marketing EMA, GSK

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …
News
imprimis_logo

Imprimis launches low-cost Daraprim alternative

October 26, 2015 Sales and Marketing Daraprim, Imprimis, Martin Skhreli, turing

Imprimis Pharmaceuticals has announced that it has made available a customisable compounded formulation of pyrimethamine and leucovorin accessible for physicians …
News
valeant_logo_on_board

CEO prepares for day of reckoning over Valeant fraud allegations

October 26, 2015 Sales and Marketing J. Michael Pearson, Valeant

Troubled Valeant Pharmaceuticals last week announced strong third quarter revenues, reporting a 36% increase in revenues to $172 million, but …
News
robert_langer

Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize

October 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize

Dr Robert Langer, the co-founder of PureTech Health, has won the Queen Elizabeth prize for engineering.The award is in recognition …
Appointment
AZ sign

FDA backs AZ gout drug despite safety concerns

October 26, 2015 Sales and Marketing AstraZeneca, Zurampic, gout, lesinurad

FDA reviewers have recommended approving AstraZeneca’s new gout therapy Zurampic, which the company purchased in a $1.3 billion buyout, despite …
News
shire_image_4

Shire reports 7% product sales growth, continues Baxalta pursuit

October 23, 2015 Sales and Marketing Baxalta, Shire

Shire has exceeded market expectations as it reported an 11% rise in Q3 earnings on Friday, driven by product sales, …
News
cosentyx_logo

Novartis’ Cosentyx gets European approval for two conditions

October 23, 2015 Medical Communications, Sales and Marketing Cosentyx, European Medicines Agency, Novartis, psoriatic arthritis

The scientific committee of the European Medicines Agency (EMA) has recommended the approval of Novartis’ Cosentyx (secukinumab) for treatment of ankylosing …
News
New Merck logo

COMPANY PROFILE: The secrets of that Merck rebrand

October 23, 2015 Medical Communications, Sales and Marketing Merck, branding, communications, corporate logo, reputation

Merck’s recent rebrand may have left many scratching their heads, as the company moved away from the clinical professionalism of …
Feature
pi

Physicians Interactive acquires Univadis portal

October 22, 2015 Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis

Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …
News
Severin Schwan

Roche buoyed by 6% sales growth

October 22, 2015 Sales and Marketing Roche, financial results

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …
News
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015 Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
News
Ezetrol

NICE issues draft guidance for MSD’s Ezetrol

October 21, 2015 Sales and Marketing MSD, NICE, cardiovascular disease, ezetimibie, ezetrol, high cholesterol

NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol.  The guidance updates …
News
Valeant logo

Valeant announces strong Q3 results, will expand US contact lens plant

October 20, 2015 Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production

Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …
News
The Gateway to Local Adoption Series

Latest content

Cori Clinical raises US$4m to expand AI platform for clinical trial design

October 14, 2026

Ofichem acquires US drug substance CDMO Kinentia

October 14, 2026

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026

Tridem begins phase Ib trial of Parkinson’s disease vaccine

October 13, 2026

Bio-Techne opens GMP small-molecule manufacturing facility in Bristol

October 13, 2026